Estriol succinate
| Clinical data | |
|---|---|
| Trade names | Synapause, others |
| Other names | Oestriol succinate; Estriol disuccinate; Estriol hemisuccinate; Succinylestriol; Estriol 16α,17β-di(hydrogen succinate) |
| Routes of administration | By mouth, vaginal |
| Drug class | Estrogen; Estrogen ester |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.007.442 |
| Chemical and physical data | |
| Formula | C26H32O9 |
| Molar mass | 488.533 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Estriol succinate, sold under the brand name Synapause among others, is an estrogen medication which is used in the treatment of menopausal symptoms. It is taken by mouth, in through the vagina, and by injection.